Regulatory News
Monday, April 11, 2016
BRIEF-Regeneron Pharmaceuticals, Intellia Therapeutics announce collaboration to discover, develop CRISPR/CAS therapeutics
* Regeneron and intellia therapeutics announce collaboration
to discover and develop crispr/cas therapeutics
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment